Тёмный

Infectious Diseases Grand Rounds: The Ins N Outs of ESBL Management 

Norton Infectious Diseases Institute
Подписаться 585
Просмотров 2,2 тыс.
50% 1

In this video of Norton Infectious Diseases Institute Grand Rounds, Clover Truong, PharmD, BCPS, BCIDP, Infectious Diseases Clinical Pharmacist, Norton Healthcare, will explore the ins and outs of ESBL management. ESBLs, or extended-spectrum beta-lactamases, are enzymes that can make bacteria resistant to certain antibiotics, leading to potentially dangerous infections. She will discuss the causes and risk factors associated with ESBL infections and the various treatment options available, including antibiotic therapy and infection prevention measures. Dr. Truong will also highlight the importance of ESBL surveillance and monitoring in healthcare settings, and the key strategies for preventing the spread of ESBLs. This video aims to raise awareness about ESBLs and provide viewers with the knowledge and resources needed to effectively manage and prevent these infections.
This program is presented by Norton Infectious Diseases Institute, located in Louisville, Kentucky, home to the Kentucky Antimicrobial Stewardship Innovation Consortium (KASIC) and the Kentucky Infection Prevention (KYIP) Training Center. For more information visit www.kymdro.org/kasic or www.KyIPTraining.org

Опубликовано:

 

9 май 2023

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии : 2   
@owensaenz1065
@owensaenz1065 5 месяцев назад
Very helpful video! Thanks.
@adukaalmizan6908
@adukaalmizan6908 5 месяцев назад
tqvm.. I'm not panic anymore..
Далее
It works! #beatbox #tiktok
00:15
Просмотров 2,5 млн
Good dad 🥰 #demariki
00:17
Просмотров 9 млн
everyone will be WIPED out in 21 days
13:23
Просмотров 298 тыс.
Infection Control Principles for Hemodialysis Settings
1:04:16
Bacteremia and Clinical Resistance
1:06:41
Просмотров 3,2 тыс.
UofL Dept. of Medicine Grand Rounds: Dr. Scott Commins
1:06:15
It works! #beatbox #tiktok
00:15
Просмотров 2,5 млн